1 Obvious Way This Consumer-Facing Stock Can Beat the S&P 500 Over the Next 3 Years

Starbucks management guided to adjusted EPS of $3.35-$4.00 in fiscal 2028 versus $2.13 in fiscal 2025, implying 73% midpoint growth, but the article argues the stock’s 46x fiscal 2025 EPS valuation leaves little margin of safety. The turnaround is showing early signs of progress, with comparable global transactions up 3% in the fiscal 2026 first quarter, yet the piece remains skeptical that execution and valuation will both cooperate. Overall, the article is cautious on the shares despite the improved outlook.

Analysis

The setup is less about Starbucks “winning” than about the market pricing in a clean turnaround before proof accumulates. A 73% EPS ramp looks powerful on paper, but at a very high forward multiple, the stock is effectively a leveraged bet on execution quality holding while labor, traffic, and consumption remain cooperative for multiple years. That combination is rare; when it works, multiples can stay elevated, but when the market starts to doubt the durability of comp recovery, de-rating can arrive well before any earnings shortfall shows up.

Second-order, the real beneficiaries of a Starbucks stall are not just direct coffee peers but mall landlords, quick-service breakfast chains, and premium beverage distributors that can absorb share if store throughput remains frustrating. If Starbucks keeps pushing labor and tech into the model, near-term margin optics may improve even while throughput is still the binding constraint, which can create an earnings “illusion” before customer lifetime value actually inflects. The risk is that operational simplification boosts reported EPS faster than same-store traffic normalizes, leaving the equity vulnerable when investors realize the growth rate is being bought at a rich price.

The contrarian view is that consensus may be underestimating how much management discipline has already been baked into the stock: if comps stay positive for another few quarters, the multiple could hold longer than skeptics expect. But the asymmetry still looks poor because the downside case is not a collapse in earnings, it is merely mid-teens growth instead of the implied acceleration, which would likely force a 20-30% multiple reset over 12-18 months. In that regime, the stock can underperform even with rising EPS, making this more of a valuation compression story than a fundamental short.

NFLX and NVDA show up here as useful contrast names: both have stronger secular reinvestment arcs and clearer ability to compound without needing a turnaround to re-rate. Starbucks, by contrast, needs both operational repair and a benign consumer backdrop; that makes the equity far more fragile to any macro wobble in the next 2-6 quarters.

Key Decisions for Investors

• Avoid initiating new long SBUX here; if holding, consider trimming into strength over the next 1-3 months because the risk/reward is skewed toward multiple compression rather than further rerating.
• Pair trade: long NVDA or NFLX vs short SBUX over a 6-12 month horizon; the long legs have cleaner duration with less execution risk, while SBUX is exposed to turnaround slippage and valuation mean reversion.
• For tactical bearish exposure, buy SBUX put spreads 6-9 months out around the next two earnings prints; target a 20-30% downside if the market begins to price in a lower terminal multiple.
• If forced to own SBUX, wait for a post-earnings pullback or any sign of comp deceleration; entry improves meaningfully if the forward multiple compresses before the fiscal 2028 narrative becomes consensus.
• Monitor monthly same-store sales and ticket vs traffic mix closely: a traffic-led recovery is bullish, but a price-led comp is a warning sign that margins may be peaking before the growth story is proven.